Articles dans des revues avec comité de lecture (45)

  1. 37. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Pieters, K., Anthoine, G., Mineur, P., Bron, D., & Lagneaux, L. (2010). A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients. PloS one, 5(9). doi:10.1371/journal.pone.0012780
  2. 38. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Mineur, P., Martiat, P., Bron, D., & Lagneaux, L. (2009). Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis. Leukemia, 23(12), 2281-2289. doi:10.1038/leu.2009.176
  3. 39. Stamatopoulos, B., Haibe-Kains, B., Equeter, C., Meuleman, N., Soree, A., De Bruyn, C., Hanosset, D., Bron, D., Martiat, P., & Lagneaux, L. (2009). Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA. Haematologica, 94(6), 790-799. doi:10.3324/haematol.2008.002626
  4. 40. Stamatopoulos, B., Meuleman, N., Haibe-Kains, B., Saussoy, P., Van Den Neste, E., Michaux, L., Heimann, P., Martiat, P., Bron, D., & Lagneaux, L. (2009). microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood, 113(21), 5237-5245. doi:10.1182/blood-2008-11-189407
  5. 41. Tondreau, T., Meuleman, N., Stamatopoulos, B., De Bruyn, C., Delforge, A., Dejeneffe, M., Martiat, P., Bron, D., & Lagneaux, L. (2009). In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy, 11(5), 559-569. doi:10.1080/14653240903051541
  6. 42. Meuleman, N., Stamatopoulos, B., Dejeneffe, M., El Housni, H., Lagneaux, L., & Bron, D. (2008). Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients. Leukemia, 22(10), 1882-1890. doi:10.1038/leu.2008.190
  7. 43. Tondreau, T., Dejeneffe, M., Meuleman, N., Stamatopoulos, B., Delforge, A., Martiat, P., Bron, D., & Lagneaux, L. (2008). Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells. BMC genomics, 9, 166. doi:10.1186/1471-2164-9-166
  8. 44. Lagneaux, L., Gillet, N., Stamatopoulos, B., Delforge, A., Dejeneffe, M., Massy, M., Meuleman, N., Kentos, A., Martiat, P., Willems, L., & Bron, D. (2007). Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Experimental hematology, 35(10), 1527-1537. doi:10.1016/j.exphem.2007.06.014
  9. 45. Stamatopoulos, B., Meuleman, N., Haibe-Kains, B., Duvillier, H., Massy, M., Martiat, P., Bron, D., & Lagneaux, L. (2007). Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clinical chemistry, 53(10), 1757-1766. doi:10.1373/clinchem.2007.089326
  10.   Participations à des congrès et colloques internationaux (28)

  11. 1. Alexandri, C., Stamatopoulos, B., Bareche, Y., Jabin, I., Bruylants, G., & Demeestere, I. (2019). Identification of let-7a as a target to prevent chemotherapy-induced ovarian damage in mouse model: a novel & non-invasive pharmacological approach in future fertility preservation strategies. Abstract session presented at fTALES Meeting(2019-09-18: Ghent)
  12. 2. Alexandri, C., Stamatopoulos, B., Bareche, Y., Jabin, I., Bruylants, G., & Demeestere, I. (2019). Identification of let-7a as a target to prevent chemotherapy-induced ovarian damage in mouse model: a novel & non-invasive pharmacological approach in future fertility preservation strategies. Poster présenté à la conférence fTALES Meeting (18/9/2019: Ghent).
  13. 3. Alexandri, C., Stamatopoulos, B., Bareche, Y., Jabin, I., Bruylants, G., & Demeestere, I. (2019). Identification of let-7a as a target to prevent chemotherapy-induced ovarian damage in mouse model: a novel & non-invasive pharmacological approach in future fertility preservation strategies: Flash oral presentation. Abstract session presented at EDT –CANCEROLOGY(06/09/2019: Brussels, Belgium)

  14. << Précédent 1 2 3 4 5 6 7 Suivant >>